Mohsen Sohi - 10 Aug 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Director
Issuer ticker: STE
Reported as of: 10 Aug 2026
Net transaction value: -$956,795
SEC form: 4
Accepted by SEC: 12 Aug 2026, 16:33:57 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Mohsen Sohi filed Form 4 for STERIS plc (STE) on 12 Aug 2026.

Key facts

This page summarizes Mohsen Sohi's Form 4 filing for STERIS plc (STE).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 16:33.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$956,795.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001293588 Primary reporting owner

Sohi Mohsen

Relationship: Director
Address: 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +4,058
Change %: +17%
Price: $86.23^*
Shares after: 28,363
Date: 12 Aug 2026
Ownership: Direct

STE transaction

Ordinary Shares

Sale

Transaction value: $956,795
Shares: -4,058
Change %: -14%
Price: $235.78
Shares after: 24,305
Date: 12 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
Shares: +1,099
Change %
Price: $0.000000^*
Shares after: 1,099
Date: 10 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,099
Exercise price: $238.91
Footnotes: F2

STE transaction Derivative

Career Restricted Stock Units

Award

Transaction value
Shares: +1,229
Change %: +16%
Price: $0.000000^*
Shares after: 8,979
Date: 10 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,229
Exercise price
Footnotes: F3, F4

STE transaction Derivative

Director Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -4,058
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 12 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 4,058
Exercise price: $86.23
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

These nonqualified stock options are fully vested and are exercisable immediately.

Footnote F3

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

Footnote F4

These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Footnote F5

This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.